{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:36:44Z","timestamp":1790642204731,"version":"4.1.0"},"reference-count":48,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Resting platelets rely on oxidative phosphorylation (OXPHOS) and aerobic glycolysis (conversion of glucose to lactate in the presence of oxygen) for their energy requirements. In contrast, platelet activation exhibits an increased rate of aerobic glycolysis relative to OXPHOS. Mitochondrial enzymes pyruvate dehydrogenase kinases (PDKs) phosphorylate the pyruvate dehydrogenase (PDH) complex to inhibit its activity, thereby diverting the pyruvate flux from OXPHOS to aerobic glycolysis upon platelet activation. Of 4 PDK isoforms, PDK2 and PDK4 (PDK2\/4) are predominantly associated with metabolic diseases. Herein, we report that the combined deletion of PDK2\/4 inhibits agonist-induced platelet functions, including aggregation, integrin \u03b1IIb\u03b23 activation, degranulation, spreading, and clot retraction. In addition, collagen-mediated PLC\u03b32 phosphorylation and calcium mobilization were significantly reduced in PDK2\/4\u2212\/\u2212 platelets, suggesting impaired GPVI signaling. The PDK2\/4\u2212\/\u2212 mice were less susceptible to FeCl3-induced carotid and laser-induced mesenteric artery thrombosis without any effect on hemostasis. In adoptive transfer experiments, thrombocytopenic hIL-4R\u03b1\/GPIb\u03b1-transgenic mice transfused with PDK2\/4\u2212\/\u2212 platelets exhibited less susceptibility to FeCl3 injury\u2013induced carotid thrombosis compared with hIL-4R\u03b1\/GPIb\u03b1-Tg mice transfused with WT platelets, suggesting a platelet-specific role of PDK2\/4 in thrombosis. Mechanistically, the inhibitory effects of PDK2\/4 deletion on platelet function were associated with reduced PDH phosphorylation and glycoPER in activated platelets, suggesting that PDK2\/4 regulates aerobic glycolysis. Finally, using PDK2 or PDK4 single KO mice, we identified that PDK4 plays a more prominent role in regulating platelet secretion and thrombosis compared with PDK2. This study identifies the fundamental role of PDK2\/4 in regulating platelet functions and identifies the PDK\/PDH axis as a potentially novel antithrombotic target.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010100","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T15:04:34Z","timestamp":1679929474000},"page":"2347-2359","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":44,"title":["Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-3094","authenticated-orcid":false,"given":"Gagan D.","family":"Flora","sequence":"first","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6461-0543","authenticated-orcid":false,"given":"Manasa K.","family":"Nayak","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6606-0108","authenticated-orcid":false,"given":"Madankumar","family":"Ghatge","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2477-3011","authenticated-orcid":false,"given":"Mariia","family":"Kumskova","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9727-9738","authenticated-orcid":false,"given":"Rakesh B.","family":"Patel","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8554-0898","authenticated-orcid":false,"given":"Anil K.","family":"Chauhan","sequence":"additional","affiliation":[{"name":"1Division of Hematology\/Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"issue":"5","key":"2023061316230122600_bib1","first-page":"753","article-title":"Can metabolic pathways be therapeutic targets in rheumatoid arthritis?","volume":"8","author":"Sanchez-Lopez","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"8","key":"2023061316230122600_bib2","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.4103\/1673-5374.213542","article-title":"Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis","volume":"12","author":"Heidker","year":"2017","journal-title":"Neural Regen Res"},{"issue":"1","key":"2023061316230122600_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41416-019-0666-4","article-title":"Development of cancer metabolism as a therapeutic target: new pathways, patient studies, stratification and combination therapy","volume":"122","author":"Harris","year":"2020","journal-title":"Br J Cancer"},{"issue":"1","key":"2023061316230122600_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmet.2019.11.014","article-title":"The untapped opportunity and challenge of immunometabolism: a new paradigm for drug discovery","volume":"31","author":"Mazumdar","year":"2020","journal-title":"Cell Metab"},{"key":"2023061316230122600_bib5","first-page":"26","article-title":"Metabolic alterations and the potential for targeting metabolic pathways in the treatment of multiple myeloma","volume":"5","author":"Rizzieri","year":"2019","journal-title":"J\u00a0Cancer Metastasis Treat"},{"issue":"15","key":"2023061316230122600_bib6","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/bloodadvances.2018022392","article-title":"Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis","volume":"2","author":"Nayak","year":"2018","journal-title":"Blood Adv"},{"issue":"12","key":"2023061316230122600_bib7","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.2020007140","article-title":"The metabolic enzyme pyruvate kinase M2 regulates platelet function and arterial thrombosis","volume":"137","author":"Nayak","year":"2021","journal-title":"Blood"},{"issue":"4","key":"2023061316230122600_bib8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3324\/haematol.2018.205724","article-title":"Aerobic glycolysis fuels platelet activation: small-molecule modulators of platelet metabolism as anti-thrombotic agents","volume":"104","author":"Kulkarni","year":"2019","journal-title":"Haematologica"},{"issue":"5","key":"2023061316230122600_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/09537104.2018.1453062","article-title":"Platelet biomechanics, platelet bioenergetics, and applications to clinical practice and translational research","volume":"29","author":"George","year":"2018","journal-title":"Platelets"},{"issue":"6","key":"2023061316230122600_bib10","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/labinvest.2013.53","article-title":"Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood","volume":"93","author":"Chacko","year":"2013","journal-title":"Lab Invest"},{"key":"2023061316230122600_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.redox.2013.12.026","article-title":"A\u00a0review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: implications for their use as bioenergetic biomarkers","volume":"2","author":"Kramer","year":"2014","journal-title":"Redox Biol"},{"issue":"4","key":"2023061316230122600_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0123597","article-title":"Metabolic plasticity in resting and thrombin activated platelets","volume":"10","author":"Ravi","year":"2015","journal-title":"PLoS One"},{"issue":"Pt 6","key":"2023061316230122600_bib13","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1042\/bst0311143","article-title":"Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation","volume":"31","author":"Holness","year":"2003","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"2023061316230122600_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-7075-11-10","article-title":"The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility","volume":"11","author":"Zhang","year":"2014","journal-title":"Nutr Metab"},{"key":"2023061316230122600_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.00944","article-title":"Pyruvate dehydrogenase kinase is a metabolic checkpoint for polarization of macrophages to the M1 phenotype","volume":"10","author":"Min","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"2023061316230122600_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-53218-x","article-title":"Non-genomic effects of the Pregnane X Receptor negatively regulate platelet functions, thrombosis and haemostasis","volume":"9","author":"Flora","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"2023061316230122600_bib17","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood.2019004575","article-title":"Structural, functional, and mechanistic insights uncover the fundamental role of orphan connexin-62 in platelets","volume":"137","author":"Sahli","year":"2021","journal-title":"Blood"},{"issue":"5","key":"2023061316230122600_bib18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/ATVBAHA.117.309207","article-title":"RXR ligands negatively regulate thrombosis and hemostasis","volume":"37","author":"Unsworth","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2023061316230122600_bib19","doi-asserted-by":"crossref","first-page":"H617","DOI":"10.1152\/ajpheart.00667.2010","article-title":"Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice","volume":"301","author":"Upmacis","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"2023061316230122600_bib20","first-page":"2969","article-title":"Sex differences in thrombosis in mice are mediated by sex-specific growth hormone secretion patterns","volume":"118","author":"Wong","year":"2008","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"2023061316230122600_bib21","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2012-01-405498","article-title":"Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor \u03b1. Blood","volume":"120","author":"Val\u00e9ra","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2023061316230122600_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/cvr\/cvy044","article-title":"Non-genomic effects of nuclear receptors: insights from the anucleate platelet","volume":"114","author":"Unsworth","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"3","key":"2023061316230122600_bib23","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/cphy.c140074","article-title":"Platelets and their interactions with other immune cells","volume":"5","author":"Lam","year":"2015","journal-title":"Compr Physiol"},{"issue":"6","key":"2023061316230122600_bib24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood-2016-05-718114","article-title":"The role of leukocytes in thrombosis","volume":"128","author":"Swystun","year":"2016","journal-title":"Blood"},{"issue":"0 1","key":"2023061316230122600_bib25","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.thromres.2014.03.002","article-title":"Adoptive transfer method to study platelet function in mouse models of disease","volume":"133 Suppl 1","author":"Bergmeier","year":"2014","journal-title":"Thromb Res"},{"issue":"2","key":"2023061316230122600_bib26","first-page":"908","article-title":"Platelet ITAM signaling is critical for vascular integrity in inflammation","volume":"123","author":"Boulaftali","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"20","key":"2023061316230122600_bib27","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood-2014-10-608653","article-title":"Cellular fibronectin containing extra domain A promotes arterial thrombosis in mice through platelet Toll-like receptor 4","volume":"125","author":"Prakash","year":"2015","journal-title":"Blood"},{"issue":"8","key":"2023061316230122600_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4049\/immunohorizons.2100068","article-title":"Role of mitochondrial dynamics in microglial activation and metabolic switch","volume":"5","author":"Montilla","year":"2021","journal-title":"Immunohorizons"},{"issue":"11","key":"2023061316230122600_bib29","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2023061316230122600_bib30","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/ATVBAHA.114.303413","article-title":"Current state and novel approaches of antiplatelet therapy","volume":"35","author":"Metharom","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 1","key":"2023061316230122600_bib31","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1111\/jth.12947","article-title":"Antiplatelet drugs: which targets for which treatments?","volume":"13","author":"Gachet","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"2023061316230122600_bib32","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1111\/jth.14274","article-title":"Glucose metabolism and metabolic flexibility in blood platelets","volume":"16","author":"Aibibula","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"2023061316230122600_bib33","doi-asserted-by":"crossref","first-page":"e22768","DOI":"10.1096\/fj.202201321RR","article-title":"Fatty acid oxidation fuels agonist-induced platelet activation and thrombus formation: Targeting \u03b2-oxidation of fatty acids as an effective anti-platelet strategy","volume":"37","author":"Kulkarni","year":"2023","journal-title":"FASEB J"},{"issue":"4","key":"2023061316230122600_bib34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/bloodadvances.2018025155","article-title":"Platelet respiration","volume":"3","author":"Kholmukhamedov","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"2023061316230122600_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/emm.2001.32","article-title":"Regulation of mammalian pyruvate dehydrogenase complex by phosphorylation: complexity of multiple phosphorylation sites and kinases","volume":"33","author":"Patel","year":"2001","journal-title":"Exp Mol Med"},{"issue":"6","key":"2023061316230122600_bib36","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3892\/ol.2012.928","article-title":"Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)","volume":"4","author":"Zheng","year":"2012","journal-title":"Oncol Lett"},{"issue":"23","key":"2023061316230122600_bib37","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","article-title":"Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation","volume":"115","author":"Krawczyk","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2023061316230122600_bib38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"Immunity"},{"key":"2023061316230122600_bib39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-065X.2010.00911.x","article-title":"The metabolic life and times of a T-cell","volume":"236 (1)","author":"Michalek","year":"2010","journal-title":"Immunol Rev"},{"issue":"5516","key":"2023061316230122600_bib40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1126\/science.1058079","article-title":"Cooperation and competition in the evolution of ATP-producing pathways","volume":"292","author":"Pfeiffer","year":"2001","journal-title":"Science"},{"issue":"10","key":"2023061316230122600_bib41","doi-asserted-by":"crossref","first-page":"200161","DOI":"10.1098\/rsob.200161","article-title":"Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle","volume":"10","author":"Dehghani","year":"2020","journal-title":"Open Biol"},{"issue":"1","key":"2023061316230122600_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","article-title":"Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies","volume":"17","author":"Kaur","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"2023061316230122600_bib43","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/09537104.2018.1492108","article-title":"Platelet reactivity in overweight and obese patients undergoing cardiac surgery","volume":"30","author":"Ranucci","year":"2019","journal-title":"Platelets"},{"issue":"4","key":"2023061316230122600_bib44","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3390\/ijms19041246","article-title":"Human cancer and platelet interaction, a potential therapeutic target","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2023061316230122600_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx071","article-title":"Therapeutic targeting of the pyruvate dehydrogenase complex\/pyruvate dehydrogenase kinase (PDC\/PDK) axis in cancer","volume":"109","author":"Stacpoole","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"2023061316230122600_bib46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4093\/dmj.2014.38.3.181","article-title":"The role of pyruvate dehydrogenase kinase in diabetes and obesity","volume":"38","author":"Lee","year":"2014","journal-title":"Diabetes Metab J"},{"issue":"1","key":"2023061316230122600_bib47","doi-asserted-by":"crossref","first-page":"188568","DOI":"10.1016\/j.bbcan.2021.188568","article-title":"Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy","volume":"1876","author":"Anwar","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"2023061316230122600_bib48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4093\/dmj.2015.39.3.188","article-title":"Pyruvate dehydrogenase kinases: therapeutic targets for diabetes and cancers","volume":"39","author":"Jeoung","year":"2015","journal-title":"Diabetes Metab J"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/11\/2347\/2056963\/blooda_adv-2023-010100-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/11\/2347\/2056963\/blooda_adv-2023-010100-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T16:23:58Z","timestamp":1686673438000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/11\/2347\/495070\/Mitochondrial-pyruvate-dehydrogenase-kinases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,6,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010100","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]}}}